Quantessence Capital LLC Buys Shares of 5,529 Corteva, Inc. (NYSE:CTVA)

Quantessence Capital LLC acquired a new position in Corteva, Inc. (NYSE:CTVA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 5,529 shares of the company's stock, valued at approximately $315,000.

Several other large investors have also recently made changes to their positions in CTVA. Flagship Wealth Advisors LLC bought a new stake in Corteva in the 4th quarter worth about $25,000. Noble Wealth Management PBC purchased a new position in Corteva in the fourth quarter worth about $26,000. Hager Investment Management Services LLC bought a new position in shares of Corteva in the 4th quarter worth approximately $27,000. Golden State Wealth Management LLC bought a new stake in Corteva during the fourth quarter valued at approximately $32,000. Finally, Centricity Wealth Management LLC bought a new position in Corteva in the fourth quarter worth approximately $34,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Corteva

In other news, insider Brian Titus sold 26,560 shares of the firm's stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total value of $1,692,934.40. Following the transaction, the insider now owns 11,347 shares in the company, valued at $723,257.78. This trade represents a 70.07 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 0.14% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on CTVA shares. BNP Paribas upgraded Corteva to a "hold" rating in a research report on Monday, February 10th. Argus upgraded shares of Corteva from a "hold" rating to a "buy" rating and set a $69.00 target price on the stock in a research note on Monday, March 31st. Bank of America upped their price target on shares of Corteva from $69.00 to $73.00 and gave the stock a "buy" rating in a research report on Tuesday, February 11th. The Goldman Sachs Group assumed coverage on shares of Corteva in a report on Thursday, March 13th. They issued a "buy" rating and a $71.00 target price for the company. Finally, KeyCorp raised their price target on Corteva from $70.00 to $71.00 and gave the company an "overweight" rating in a report on Monday, April 14th. One analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $68.13.

Corteva Stock Down 0.0 %

Shares of NYSE:CTVA traded down $0.01 during trading on Monday, reaching $61.46. The stock had a trading volume of 725,789 shares, compared to its average volume of 3,556,893. Corteva, Inc. has a one year low of $50.01 and a one year high of $66.24. The firm's 50-day simple moving average is $60.71 and its 200 day simple moving average is $60.44. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $41.98 billion, a P/E ratio of 47.65, a PEG ratio of 1.68 and a beta of 0.73.

Corteva (NYSE:CTVA - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. As a group, research analysts expect that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.